Moneycontrol PRO
HomeNewsBusinessMarketsTrade Spotlight: How should you trade Orchid Pharma, India Glycols, Inox Green Energy, NBCC, and others on Tuesday?

Trade Spotlight: How should you trade Orchid Pharma, India Glycols, Inox Green Energy, NBCC, and others on Tuesday?

A close above 24,500 could drive the Nifty 50 towards the 24,700-24,800 zone, but if it stays below this level, consolidation and range-bound trading may continue with 24,200 as support. Here are some trading ideas for the near term.

August 13, 2024 / 00:10 IST
Trading Ideas
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    The market showed a smart recovery of losses, tracking positive global cues, and closed flat with a negative bias on August 12. The market breadth was slightly in favour of bears, with about 1,267 shares declining against 1,136 advancing shares on the NSE. A close above 24,500 could drive the Nifty 50 towards the 24,700-24,800 zone, but if it stays below this level, consolidation and range-bound trading may continue with 24,200 as support. Here are some trading ideas for the near term:

    Pravesh Gour, Senior Technical Analyst at Swastika Investmart

    Eveready Industries | CMP: Rs 473

    Image1512082024

    Eveready Industries has broken out of a multi-year pattern above Rs 465 levels on the longer timeframe with strong volume. The structure is very promising, as it is trading above all of its moving averages. The MACD (Moving Average Convergence Divergence) supports the current strength, while the momentum indicator RSI (Relative Strength Index) is also positively poised. On the higher side, Rs 500 acts as a significant level; above this, we can expect a move towards Rs 540+ in the shorter to longer timeframe. On the downside, Rs 440 serves as important support during any correction.

    Strategy: Buy

    Target: Rs 540

    Stop-Loss: Rs 440

    Inox Green Energy Services | CMP: Rs 189

    Image1612082024

    Inox Green Energy Services is emerging from a long consolidation with strong volume. The pattern suggests an immediate target of Rs 200, with the potential to move further upside to the Rs 216 level. On the downside, Rs 170 will act as immediate support. The MACD supports the current strength, and the momentum indicator RSI is also positively poised.

    Strategy: Buy

    Target: Rs 216

    Stop-Loss: Rs 170

    India Glycols | CMP: Rs 1,288

    Image1712082024

    India Glycols has given a breakout of a multi-year pattern above Rs 1,150 levels on the longer timeframe with strong volume. After showing some profit booking from higher levels, it retested its last breakout levels around Rs 1,150. Now, it is starting a new leg of a rally towards Rs 1,400 levels. The structure is very attractive, as it is trading above all of its moving averages. The MACD supports the current strength, while the momentum indicator RSI is also positively poised.

    Strategy: Buy

    Target: Rs 1,420

    Stop-Loss: Rs 1,190

    Kushal Gandhi, Technical Analyst at StoxBox

    NBCC (India) | CMP: Rs 182

    Image1812082024

    Upon analysing the daily timeframe, the price action in NBCC exhibited a modest decline following an 88 percent increase from the March 2024 lows. This decline did not negate the bullish breakout from the rounding bottom pattern, which is a favourable sign for trend continuation. It also suggests the presence of committed investors retaining their positions, thereby limiting potential drawdowns. Notably, the price action underwent a notable technical pullback following a retest of the breakout zone and its 50-day moving average, accompanied by heightened volume and momentum, signaling inherent strength.

    Strategy: Buy

    Target: Rs 230

    Stop-Loss: Rs 167

    Orchid Pharma | CMP: Rs 1,478.5Image1912082024

    The analysis of Orchid Pharma's pattern indicates a substantial price movement following a surge in price action after a volatility contraction pattern. These observations suggest potential signs of accumulation by informed investors. As the trend has progressed, accumulation phases have been evident in the price action, hinting at further accumulation to bolster the continuation of the trend. Notably, the stock exhibits higher relative strength compared to the Nifty, coupled with heightened demand from buyers. Consequently, a positive outlook on the stock is warranted.

    Strategy: Buy

    Target: Rs 1,720

    Stop-Loss: Rs 1,381

    FSN E-Commerce Ventures | CMP: Rs 194.6

    Image2012082024

    The price action of Nykaa has entered an extended phase of consolidation after a 73 percent decline from its all-time high. This prolonged consolidation phase indicates accumulation by astute investors, mitigating the stock's downturns. Notably, the price trend on the weekly timeframe, starting from the April 2023 lows, demonstrates a pattern of higher highs and lows, signaling an improving trend. Additionally, the recent price action depicts a rounding bottom pattern, implying potential indications of a positive trend continuation, offering an opportunity with favourable risk-reward characteristics.

    Strategy: Buy

    Target: Rs 235

    Stop-Loss: Rs 180

    Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Sunil Shankar Matkar
    first published: Aug 13, 2024 12:10 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347